Vitamin K deficiency and D-dimer levels in the intensive care unit: A prospective cohort study

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 1, 2002, Pages 49-52

  Crowther, M A ^a   McDonald, E ^a   Johnston, M ^b   Cook, D ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

Coagulopathy; Critical illness; Factor II; Intensive care unit; Vitamin K deficiency

Indexed keywords

D DIMER; HEPARIN; PROTHROMBIN; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; COHORT ANALYSIS; CRITICAL ILLNESS; FEMALE; HIGH RISK POPULATION; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; COHORT STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMORRHAGE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN K DEFICIENCY;

EID: 0036236028     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200201000-00007     Document Type: Article

References (5)

1. The incidence and cause of coagulopathies in an intensive care population
2. Six years' experience of prophylactic oral vitamin K
3. Treatment of warfarin-associated coagulopathy with oral vitamin K: A randomized clinical trial
4. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation
5. Reversal of excessive effect of regular anticoagulation: Low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation